Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Max Healthcare Institute GST demand of ₹55 crore fully withdrawn after rectification order
Shares of Max Healthcare Institute Ltd ended at ₹1,021.50, up by ₹11.15, or 1.10%, on the BSE.
AVI Polymers board to meet on Apr 27 to discuss results, dividend, mull healthcare entry
AVI Polymers board will meet April 27 2026 to approve FY26 audited results, consider up to 50 percent dividend, and review an AI led healthcare tech expansion via AVI AI Technologies
'Weak and lacklustre': Why Jefferies is disappointed with Wipro earnings as ADRs fall nearly 3%
Wipro’s March quarter results missed expectations, with weak revenue growth, declining profit, and soft guidance. Jefferies highlighted slowing deal momentum, weakness in BFSI and healthcare, and client-specific declines, raising concerns over near-term growth despite stable margins and a buyback announcement.
Eye on aspirational India, medical tourism, Max Healthcare steps up bed capacity expansion
Max Healthcare Institute Ltd is expanding capacity to 10,000 beds over the next 3–4 years, investing ₹4,000–5,000 crore to meet rising domestic demand and boost medical tourism.
NCLEX-RN explained: What has changed and why it matters for Indian nurses
The NCLEX-RN exam, a crucial step for Indian nurses seeking overseas careers, has adopted a new format emphasizing clinical judgment and real-world application. This shift, particularly impacting Kerala's nursing talent, requires a move from rote memorization to conceptual understanding and practical problem-solving, aligning preparation with global healthcare demands.
Wipro Q4 Preview: Profit may fall on margin pressures. Is buyback the only thing to cheer?
Wipro is expected to report steady revenue growth but weaker profitability in the March quarter, impacted by wage hikes, acquisition-related costs and subdued discretionary spending. Sequential growth remains muted despite acquisition support, while BFSI shows resilience, and healthcare remains weak. Investors will closely track margins, deal pipeline and AI outlook.
US market outlook stable; India to gain from supply chain shift: Oppenheimer Asset Management
John Stoltzfus, MD and Chief Investment Strategist, Oppenheimer Asset Management, said that over the medium term, diversification of global supply chains and sectoral strengths in technology, healthcare, and manufacturing are expected to support growth across regions, including a potential recovery in India’s relative performance.
KKR-backed Baby Memorial to acquire 60% stake in Star Hospitals for ₹1,800 crore
Baby Memorial Hospital will acquire around 60% stake in the Hyderabad hospital chain's parent company, Unimed Healthcare.
Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 million
Nasdaq-listed company will be largest buyout for tech company till date. Will give boost for revenue cycle management offerings.
Pharma and healthcare companies to face continued margin pressure: HDFC Securities
The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC Securities. "We project sales/EBITDA growth of 11%/6% YoY for our coverage universe," the brokerage added.
BofA cuts Definitive Healthcare stock price target on weak guidance By Investing.com - Investing.com India
BofA cuts Definitive Healthcare stock price target on weak guidance By Investing.comInvesting.com India
What stock market values more? Nithin Kamath of Zerodha flags a paradox investors can’t ignore
Zerodha's Nithin Kamath raises concerns about market valuations, noting that financial firms often outpace essential healthcare providers like Narayana Hospitals. He emphasizes the oddity of valuing businesses closer to profit more highly than those providing critical life-saving services.